Novogene Co., Ltd.
SHH: 688315.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ruiqiang Li
- Employees
- 2,202
- Headquarters
- Beijing, China
- IPO year
- 2021
- Market cap
- CN¥6.3B
- Website
- https://www.novogene.com
Loading 688315…
Loading profile data…Frequently asked questions about 688315
What does Novogene Co., Ltd. (688315.SS) do?
Novogene Co., Ltd. provides genomic services and solutions worldwide. The company offers genomic solutions, such as human genome sequencing, gene regulation, single cell sequencing, animal and plant solutions, and microbial genome sequencing; and cancer genomic profiling, whole exome sequencing, and FFPE RNA sequencing, as well as clinical-grade...
Where does 688315.SS trade?
Novogene Co., Ltd. (688315.SS) trades on the Shanghai Stock Exchange.
What sector is 688315.SS in?
Novogene Co., Ltd. (688315.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Novogene Co., Ltd.?
Ruiqiang Li is the chief executive officer of Novogene Co., Ltd. (688315.SS).
Where is Novogene Co., Ltd. headquartered?
Novogene Co., Ltd. is headquartered in China.
Does 688315.SS pay a dividend?
Yes — Novogene Co., Ltd. (688315.SS) paid a trailing twelve-month dividend of CNY 0.05 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688315.SS go public?
Novogene Co., Ltd. (688315.SS) completed its initial public offering in 2021.